Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Lapatinib and/or Trastuzumab with Chemotherapy in HER2+ Breast Cancer
NCT00524303Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2007
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib in Invasive breast cancer (IBC), sponsored by GSK. Started Aug 2007; status: completed.
02
Drugs
lapatinib
03
Conditions
Invasive breast cancer (IBC)
Beyond the preview
Go deeper on NCT00524303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00524303.